May 2 |
Collegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
|
Apr 29 |
Collegium enters authorized generic agreement with Hikma for Nucynta franchise
|
Apr 29 |
Collegium (COLL) to Report Q1 Earnings: Here's What to Expect
|
Apr 29 |
Collegium Announces Authorized Generic Agreement with Hikma Pharmaceuticals USA Inc. for Nucynta® and Nucynta® ER
|
Apr 25 |
Collegium to Report First Quarter 2024 Financial Results on May 9, 2024
|
Apr 17 |
Is Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) ROE Of 25% Impressive?
|
Apr 11 |
Critical Insights From Collegium Pharmaceutical Analyst Ratings: What You Need To Know
|
Apr 11 |
Collegium Pharmaceutical to redeem outstanding 2.625% convertible senior notes due 2026
|
Apr 11 |
Collegium Pharmaceutical, Inc. Announces Redemption of Outstanding 2.625% Convertible Senior Notes Due 2026
|
Apr 9 |
Collegium Pharmaceutical (COLL) Stock Sinks As Market Gains: What You Should Know
|